Drug class
Pancreatic enzyme replacement therapy; digestive enzyme preparation
Mechanism of action
Provides exogenous pancreatic lipase, protease and amylase to replace deficient digestive enzymes in exocrine pancreatic insufficiency, supporting digestion of dietary fats, proteins and carbohydrates.
General use cases
- Treatment of exocrine pancreatic insufficiency associated with cystic fibrosis, chronic pancreatitis, pancreatectomy or other conditions causing pancreatic enzyme deficiency; formulation and dose are based on lipase units and product labelling.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
